Endura Technologies Appoints Michael Brunolli as Head of Research and Development
Brunolli's appointment comes as Endura Technologies' 150MHz silicon-proven Vertically Fully Integrated Voltage Regulator (VFIVR) is entering deployment with Tier-1 partners. This critical technology directly addresses the urgent performance and energy efficiency needs within hyperscale AI compute environments.
"Michael has worked closely with me for nearly two decades," said Dr.
"AI infrastructure demands a new class of power systems—ones that are vertically integrated, highly efficient, and production-ready at scale," said Brunolli. "I'm thrilled to join Endura Technologies at this pivotal moment and help bring these disruptive solutions into volume deployment."
In his new role, Brunolli will be responsible for expanding Endura Technologies' vision in powering AI factories and driving the development of the company's next-generation 300MHz voltage regulator architectures.
Learn more at www.enduratechnologies.com
About Endura Technologies
Endura Technologies develops ultra-high density power management solutions to efficiently power advanced SoCs, GPUs and chiplets. Its patented, agnostic digital architecture is engineered to scale with advanced process nodes to meet the growing demands of tomorrow's AI factories. By offering industry-leading current density, ultra-high switching frequency, ultra-fast transient response and ultra-low ripple, Endura Technologies' solutions effectively overcome the physical limitations of traditional power delivery solutions, enabling seamless integration into next-generation 2.5D and 3D AI system architectures.
Media Contact
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/endura-technologies-appoints-michael-brunolli-as-head-of-research-and-development-302488889.html
SOURCE Endura Technologies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
- HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Can
- Crypto Update: MSCI Threatens $2B in Forced Selling While Pepeto Presale Captures What Large Caps Left Behind
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share